S&P Global
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
@yenoms You think $BX or anyone can take this one down?
$DIS making a comeback attempt from "fallen angel" status...
@challeyok You can go look at the GFC performance for $PSA The coverage ratio is 6.1x, will need NOI/EBITDA to fall over 80% before they have distribution issues
For Passive Income folks I think the $PSA Prefs yielding 7.3% is the best risk reward and have a 11% price appreciation upsde. I went back and looked at spreads/coverage ratios going back to early 2000s Not everyone's cup of tea, but great for passive income Seriously thinking about putting 30% to 100% of my MIL/FIL IRA in these
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Deckers Outdoor trades at 12 times trailing earnings as HOKA and UGG grow, while buybacks could retire 8% of shares and support EPS.
Steve Eisman, Dan Ives and Gil Luria assess how the midterms could reshape AI data-center spending, Google search growth, and competition…
Reddit's search-traffic selloff overlooks that logged-in app users generate more than 80% of monetization, supporting a $130 one-year…
FactSet CEO Sanoke Viswanathan discusses using the firm’s client relationships and data platform to deploy AI across finance.
Accenture reported 6.5% FY26 revenue growth and $11.6 billion in free cash flow, while fixed-price contracts above 65% of bookings retain…
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
Ondas reported $167.5 million in Q3 revenue but spent $562 million of cash, halved gross margin and fell below its $6 stop level.
Offshore Radar maps 160-plus listed offshore rigs, contracts, day rates and uncontracted capacity through 2029.
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
BSX · long Boston Scientific, the interventional cardiac-device leader, is rated long after a share-price and P/E decline tied to slower market growth…
CoreWeave funds GPU data-center expansion with debt backed by $104 billion in contracted revenue, while GPU cloud rentals generate roughly…
Texas Instruments, ON Semiconductor and Vishay are rated Accumulate on rising robotics demand for analog, power and discrete chips after a…
Firefly Aerospace grew backlog to $1.5 billion, won two 2028 lunar missions and acquired Space-ng for autonomous navigation across its Blue…
Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…
Abbott’s Exact Sciences acquisition raises leverage, leaving Medical Devices’ 8% growth and 33.9% margin to carry cash flow until…
Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…
McDonald’s trades at $248 versus a $309.29 intrinsic-value estimate as its U.S.
Credo Technology was added at $170.54 after a 40% selloff, backed by its high-speed AECs and optical connectivity for AI data centers.
Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.